ESMO Calls on the European Commission to Fund Cancer Research and Allocate Funding of at Least €200 Billion to the 10th EU Framework Programme (FP10) Under the Upcoming EU Long-Term Budget

Providing robust EU funding to cancer research is a key requisite for driving the development of innovative cancer treatments, meeting unmet needs of patients with cancer, and supporting the work of medical oncologists in Europe and beyond

Source